Aktana was founded by David J. Ehrlich, Derek Choy.

Who are Aktana's investors?

Aktana's investors include 1315 Capital, HLM Investment Partners, Norwest Venture Partners, Starfish Ventures, TRANSFORMATION CAPITAL, Upfront Ventures, B4 Capital.

How much funding has Aktana raised?

Aktana has disclosed $75.3M raised across 4 rounds.

Where is Aktana headquartered?

Aktana is headquartered in San Francisco, US.

Aktana

San Francisco, US · Delaware corporation · 209 employees on LinkedIn · 7 known investors

Find your way into Aktana

Paths you didn't know you had: your email and LinkedIn already hold routes to the Aktana team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Aktana provides a real-time orchestration platform for pharmaceutical marketing that coordinates digital and field engagement across channels to reach healthcare professionals at optimal times. The system delivers healthcare professional-level impact tracking and enables rapid campaign deployment for pharma companies and their marketing teams.

AI & Machine Learning Enterprise Software Sales Tech

Founders & leadership

David J. EhrlichCo-founder

Derek Choy Co-founder · Head of ProductDerek Choy co-founded Aktana, an AI platform for pharmaceutical field orchestration and marketing decisioning, which was acquired by PharmaForceIQ where he now leads product. He previously worked as a management consultant at BCG, practiced commercial law in Australia, and held a cross-functional product role at Intuit.

Jin HuangExecutive

Rob WillsonExecutive

Marc-david CohenExecutive

Board

Anthony GlenningBoard director

Eric GilbertBoard director

Al WiegmanBoard director

Investors · 7

1315 Capitallisted by 1315 CapitalPhiladelphia · $5M – $40M

How we know: 1315 Capital's portfolio page · Not right? Tell us

HLM Investment Partnerslisted by HLM Investment PartnersWaltham · $3M – $5M

How we know: open dataset · 5k.vc investor directory · Not right? Tell us

Norwest Venture Partnerslisted by Norwest Venture PartnersMenlo Park · $10M – $30M

How we know: Norwest Venture Partners's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us

Starfish Ventureslisted by Starfish VenturesMelbourne · $2M – $3.3M

How we know: Starfish Ventures's portfolio page · Not right? Tell us

TRANSFORMATION CAPITALlisted by TRANSFORMATION CAPITALBoston

How we know: a partner's Signal profile · board seat on SEC Form D · Not right? Tell us

Upfront Ventureslisted by Upfront VenturesLos Angeles · $1M – $10M

B4 Capitalinferred$10M – $50Mvia Robert Mittendorff · board

How we know: board seat on SEC Form D · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$75.3M disclosed across 4 rounds · 2016–2020

▶$14.6MraisedOct 2020 · 13 investors · Other Technology

Rule 506(b)

Officers, directors & promoters on the filing

Doug DennerlineDirector
Robert MittendorffDirector
David J. EhrlichExecutive Officer, Director
John DysonDirector
Derek ChoyExecutive Officer, Director
Gary KurtzmanDirector
Jared KesselheimDirector
Colm CallanExecutive Officer

Offering amount: $14.6M
Amount sold: $14.6M
First sale: Sep 2019
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$30MraisedOct 2020 · 8 investors · Other Technology

Rule 506(b)

Officers, directors & promoters on the filing

Robert MittendorffDirector
David J. EhrlichExecutive Officer, Director
John DysonDirector
Derek ChoyExecutive Officer, Director
Doug DennerlineDirector
Jared KesselheimDirector
Gary KurtzmanDirector
Colm CallanExecutive Officer

Offering amount: $30M
Amount sold: $30M
First sale: Sep 2020
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$21.1MraisedOct 2018 · 9 investors · Other Technology

Rule 506(b)

Officers, directors & promoters on the filing

John DysonDirector
Jared KesselheimDirector
David J. EhrlichExecutive Officer, Director
Richard Van HoesenExecutive Officer
Gary KurtzmannDirector
Derek ChoyExecutive Officer, Director

Offering amount: $21.1M
Amount sold: $21.1M
First sale: Sep 2018
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$9.6MraisedJun 2016 · 11 investors · Other Technology

Rule 506(b)

Officers, directors & promoters on the filing

Anthony GlenningDirector
Jin HuangExecutive Officer
Al WiegmanDirector
Rob WillsonExecutive Officer
Eric GilbertDirector
Marc-david CohenExecutive Officer
David J. EhrlichExecutive Officer, Director
Derek ChoyExecutive Officer, Director

Offering amount: $17.6M
Amount sold: $9.6M
First sale: Jun 2016
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 5

Altana AIAltana operates an AI-powered network platform that connects businesses, logistics providers, and government agencies to automate global trade compliance and supply chain visibility through a shared system of record for product information and value chains. The platform uses agentic AI workflows to trace products from raw materials to finished goods, enabling enterprises to reduce tariff costs and build supply chain resilience while helping regulators enforce trade and economic security policies.

CircanaCircana provides predictive analytics, data, and AI technology to consumer packaged goods companies, manufacturers, and retailers to measure market share, understand consumer behavior, and accelerate growth. The company operates Liquid Data, a technology platform powered by six decades of domain expertise and high-quality datasets covering 26 industries.

AlomanaAlomana is an enterprise AI operating system that deploys autonomous AI agents to run business processes end-to-end across finance, sales, and operations. Agents run in a dedicated single-tenant instance and execute automations without manual oversight, with full auditability and compliance built in.

TanaTana is a workspace platform designed to help humans, teams, and computers collaborate more effectively. The company serves knowledge workers and teams seeking to improve how they organize information and work together.

AnumanaAnumana is an AI-driven health technology company developing software-as-a-medical-device (SaMD) solutions that apply AI to standard 12-lead ECG data to detect early signs of cardiovascular disease and support clinical decision-making. Its portfolio includes FDA-cleared ECG-AI algorithms, generative imaging applications, and real-time procedural support tools for use across diagnostic and intraprocedural cardiac care.

Companies working in the same space as Aktana.

Acquisitions · 1

Early investors' stakes continue via these deals

Tact

Frequently asked questions

What does Aktana do?: Aktana provides a real-time orchestration platform for pharmaceutical marketing that coordinates digital and field engagement across channels to reach healthcare professionals at optimal times. The system delivers healthcare professional-level impact tracking and enables rapid campaign deployment for pharma companies and their marketing teams.
Who founded Aktana?: Aktana was founded by David J. Ehrlich, Derek Choy.
Who are Aktana's investors?: Aktana's investors include 1315 Capital, HLM Investment Partners, Norwest Venture Partners, Starfish Ventures, TRANSFORMATION CAPITAL, Upfront Ventures, B4 Capital.
How much funding has Aktana raised?: Aktana has disclosed $75.3M raised across 4 rounds.
Where is Aktana headquartered?: Aktana is headquartered in San Francisco, US.